Drugs / 18F-FAPIBiotin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06734572 | Jun 2024 → Oct 2025 overdue | cancer | First Affiliated Hospital of Fujian Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FAPI-Biotin | “As a new dual targeting PET radiotracer, 18F-FAPI-Biotin is promising as an excellent imaging agent applicable to various cancers.” NCT06734572 ↗ |
| Modality | Diagnostic / imaging agent | “imaging agent” NCT06734572 ↗ |
| Route | Intravenous | “given intravenously.” NCT06734572 ↗ |